Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.
|
J Virol
|
2013
|
4.98
|
2
|
Mechanisms of GII.4 norovirus persistence in human populations.
|
PLoS Med
|
2008
|
4.57
|
3
|
Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59.
|
J Virol
|
2002
|
4.29
|
4
|
Norwalk virus: how infectious is it?
|
J Med Virol
|
2008
|
3.93
|
5
|
Genetic analysis of complex traits in the emerging Collaborative Cross.
|
Genome Res
|
2011
|
3.25
|
6
|
Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice.
|
J Virol
|
2002
|
2.98
|
7
|
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.
|
Proc Natl Acad Sci U S A
|
2003
|
2.82
|
8
|
Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.
|
J Virol
|
2009
|
2.60
|
9
|
Cellular and humoral immunity following Snow Mountain virus challenge.
|
J Virol
|
2005
|
2.59
|
10
|
Viral shape-shifting: norovirus evasion of the human immune system.
|
Nat Rev Microbiol
|
2010
|
2.53
|
11
|
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.
|
Proc Natl Acad Sci U S A
|
2012
|
2.42
|
12
|
Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice.
|
J Virol
|
2005
|
2.22
|
13
|
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane.
|
J Virol
|
2007
|
2.18
|
14
|
Rapid generation of a mouse model for Middle East respiratory syndrome.
|
Proc Natl Acad Sci U S A
|
2014
|
2.17
|
15
|
Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs.
|
J Virol
|
2005
|
2.05
|
16
|
Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
|
PLoS Pathog
|
2012
|
2.02
|
17
|
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.
|
Proc Natl Acad Sci U S A
|
2008
|
1.97
|
18
|
Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.
|
Immunol Rev
|
2008
|
1.96
|
19
|
A decade after SARS: strategies for controlling emerging coronaviruses.
|
Nat Rev Microbiol
|
2013
|
1.94
|
20
|
Heterologous gene expression from transmissible gastroenteritis virus replicon particles.
|
J Virol
|
2002
|
1.85
|
21
|
Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions.
|
J Virol
|
2004
|
1.80
|
22
|
Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling.
|
MBio
|
2010
|
1.79
|
23
|
Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.
|
J Virol
|
2007
|
1.75
|
24
|
Evidence supporting a zoonotic origin of human coronavirus strain NL63.
|
J Virol
|
2012
|
1.75
|
25
|
Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.
|
Vaccine
|
2006
|
1.74
|
26
|
Norovirus GII.4 strain antigenic variation.
|
J Virol
|
2010
|
1.73
|
27
|
Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.
|
Proc Natl Acad Sci U S A
|
2013
|
1.73
|
28
|
The nsp2 replicase proteins of murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral replication.
|
J Virol
|
2005
|
1.71
|
29
|
Heterotypic humoral and cellular immune responses following Norwalk virus infection.
|
J Virol
|
2009
|
1.70
|
30
|
Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.
|
PLoS Pathog
|
2008
|
1.69
|
31
|
Antibody is critical for the clearance of murine norovirus infection.
|
J Virol
|
2008
|
1.69
|
32
|
Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.
|
J Virol
|
2013
|
1.68
|
33
|
Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.
|
PLoS Pathog
|
2010
|
1.67
|
34
|
Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling.
|
J Virol
|
2009
|
1.58
|
35
|
Natural strain variation and antibody neutralization of dengue serotype 3 viruses.
|
PLoS Pathog
|
2010
|
1.56
|
36
|
Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice.
|
J Virol
|
2005
|
1.54
|
37
|
Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
|
J Virol
|
2011
|
1.53
|
38
|
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.
|
J Virol
|
2009
|
1.51
|
39
|
Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.
|
J Infect Dis
|
2013
|
1.47
|
40
|
MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
|
PLoS Pathog
|
2008
|
1.47
|
41
|
Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.
|
PLoS Pathog
|
2013
|
1.43
|
42
|
Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus.
|
MBio
|
2013
|
1.41
|
43
|
Cynomolgus macaque as an animal model for severe acute respiratory syndrome.
|
PLoS Med
|
2006
|
1.40
|
44
|
Norovirus immunity and the great escape.
|
PLoS Pathog
|
2012
|
1.40
|
45
|
Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.
|
J Virol
|
2012
|
1.36
|
46
|
Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
|
J Virol
|
2002
|
1.36
|
47
|
Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice.
|
G3 (Bethesda)
|
2012
|
1.35
|
48
|
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon.
|
Curr Opin Virol
|
2012
|
1.33
|
49
|
A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.
|
J Virol
|
2011
|
1.32
|
50
|
Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replication.
|
J Virol
|
2004
|
1.32
|
51
|
SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
|
PLoS Pathog
|
2010
|
1.32
|
52
|
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
|
J Virol
|
2011
|
1.29
|
53
|
A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease.
|
Nat Med
|
2012
|
1.26
|
54
|
Norovirus infectivity in humans and persistence in water.
|
Appl Environ Microbiol
|
2011
|
1.26
|
55
|
Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.
|
J Infect Dis
|
2013
|
1.23
|
56
|
Systematic assembly of a full-length infectious clone of human coronavirus NL63.
|
J Virol
|
2008
|
1.23
|
57
|
Characterization of the homo- and heterotypic immune responses after natural norovirus infection.
|
J Med Virol
|
2005
|
1.23
|
58
|
Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication.
|
J Virol
|
2007
|
1.22
|
59
|
Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genome.
|
Proc Natl Acad Sci U S A
|
2006
|
1.22
|
60
|
Retracted
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
|
Proc Natl Acad Sci U S A
|
2014
|
1.19
|
61
|
Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity.
|
RNA Biol
|
2011
|
1.18
|
62
|
Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010.
|
J Clin Microbiol
|
2011
|
1.18
|
63
|
Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.
|
J Virol
|
2009
|
1.17
|
64
|
Improved quality control processing of peptide-centric LC-MS proteomics data.
|
Bioinformatics
|
2011
|
1.15
|
65
|
Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus.
|
J Virol
|
2013
|
1.15
|
66
|
Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.
|
PLoS Negl Trop Dis
|
2012
|
1.14
|
67
|
Novel influenza virus NS1 antagonists block replication and restore innate immune function.
|
J Virol
|
2008
|
1.11
|
68
|
Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection.
|
J Virol
|
2014
|
1.11
|
69
|
Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion.
|
J Virol
|
2007
|
1.10
|
70
|
Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
|
J Virol
|
2014
|
1.10
|
71
|
Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells.
|
J Virol
|
2013
|
1.08
|
72
|
Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.
|
J Virol
|
2011
|
1.07
|
73
|
Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus.
|
J Infect Dis
|
2010
|
1.07
|
74
|
Effect of mutations in the mouse hepatitis virus 3'(+)42 protein binding element on RNA replication.
|
J Virol
|
2005
|
1.07
|
75
|
Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
|
J Virol
|
2010
|
1.07
|
76
|
Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis.
|
J Virol
|
2007
|
1.06
|
77
|
Molecular pathology of emerging coronavirus infections.
|
J Pathol
|
2015
|
1.05
|
78
|
Analysis of murine hepatitis virus strain A59 temperature-sensitive mutant TS-LA6 suggests that nsp10 plays a critical role in polyprotein processing.
|
J Virol
|
2007
|
1.04
|
79
|
Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury.
|
MBio
|
2013
|
1.04
|
80
|
Molecular surveillance of enterovirus and norwalk-like virus in oysters relocated to a municipal-sewage-impacted gulf estuary.
|
Appl Environ Microbiol
|
2003
|
1.01
|
81
|
Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infection.
|
MBio
|
2011
|
1.01
|
82
|
Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.
|
PLoS Pathog
|
2010
|
0.99
|
83
|
Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.
|
J Virol
|
2013
|
0.98
|
84
|
Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.
|
J Virol
|
2010
|
0.95
|
85
|
A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
|
MBio
|
2014
|
0.95
|
86
|
mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.
|
J Biol Chem
|
2009
|
0.92
|
87
|
Identification of cross-reactive norovirus CD4+ T cell epitopes.
|
J Virol
|
2010
|
0.91
|
88
|
Severe acute respiratory syndrome coronavirus nsp9 dimerization is essential for efficient viral growth.
|
J Virol
|
2009
|
0.89
|
89
|
SARS CoV replication and pathogenesis in human airway epithelial cultures.
|
Adv Exp Med Biol
|
2006
|
0.89
|
90
|
A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses.
|
PLoS One
|
2013
|
0.87
|
91
|
A novel mutation in murine hepatitis virus nsp5, the viral 3C-like proteinase, causes temperature-sensitive defects in viral growth and protein processing.
|
J Virol
|
2008
|
0.87
|
92
|
Emerging human coronaviruses--disease potential and preparedness.
|
N Engl J Med
|
2012
|
0.86
|
93
|
SARS coronavirus accessory ORFs encode luxury functions.
|
Adv Exp Med Biol
|
2006
|
0.85
|
94
|
The nsp2 proteins of mouse hepatitis virus and SARS coronavirus are dispensable for viral replication.
|
Adv Exp Med Biol
|
2006
|
0.83
|
95
|
The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death.
|
J Virol
|
2009
|
0.83
|
96
|
Reverse genetic analysis of the transcription regulatory sequence of the coronavirus transmissible gastroenteritis virus.
|
J Virol
|
2004
|
0.83
|
97
|
Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study.
|
Leuk Res
|
2009
|
0.82
|
98
|
RNA dimerization plays a role in ribosomal frameshifting of the SARS coronavirus.
|
Nucleic Acids Res
|
2012
|
0.82
|
99
|
Protein co-expression network analysis (ProCoNA).
|
J Clin Bioinforma
|
2013
|
0.82
|
100
|
Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b.
|
Adv Exp Med Biol
|
2006
|
0.81
|
101
|
Renilla luciferase as a reporter to assess SARS-CoV mRNA transcription regulation and efficacy of anti-SARS-CoV agents.
|
Adv Exp Med Biol
|
2006
|
0.81
|
102
|
A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression.
|
Cancer Causes Control
|
2010
|
0.80
|
103
|
Altering SARS coronavirus frameshift efficiency affects genomic and subgenomic RNA production.
|
Viruses
|
2013
|
0.80
|
104
|
Systematic assembly and genetic manipulation of the mouse hepatitis virus A59 genome.
|
Methods Mol Biol
|
2008
|
0.80
|
105
|
Association between herpes simplex virus type 1 and Helicobacter pylori in US adolescents.
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2006
|
0.79
|
106
|
The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.
|
Virology
|
2013
|
0.78
|
107
|
Detection of enteroviruses in shellfish by fluorogenic polymerase chain reaction integrated with 96-well microplate scanning.
|
J AOAC Int
|
2002
|
0.78
|
108
|
Mutational analysis of MHV-A59 replicase protein-nsp10.
|
Adv Exp Med Biol
|
2006
|
0.78
|
109
|
Bugs in the system.
|
Immunol Rev
|
2013
|
0.78
|
110
|
Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques.
|
PLoS One
|
2011
|
0.78
|
111
|
Spike gene determinants of mouse hepatitis virus host range expansion.
|
Adv Exp Med Biol
|
2006
|
0.77
|
112
|
MHV-A59 ORF1a replicase protein nsp7-nsp10 processing in replication.
|
Adv Exp Med Biol
|
2006
|
0.76
|
113
|
A Simulation Framework to Investigate in vitro Viral Infection Dynamics.
|
J Comput Sci
|
2013
|
0.75
|
114
|
Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design?
|
Expert Rev Vaccines
|
2014
|
0.75
|
115
|
Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection.
|
Emerg Infect Dis
|
2017
|
0.75
|
116
|
A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.
|
bioRxiv
|
2022
|
0.75
|
117
|
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains.
|
bioRxiv
|
2022
|
0.75
|
118
|
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2.
|
bioRxiv
|
2020
|
0.75
|
119
|
Corrigendum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.
|
Nat Med
|
2016
|
0.75
|